BridgeMD
New treatment option for Decompensated Cirrhosis
Official title Hospital @ Home Model of Care for Cirrhosis
ClinicalTrials.gov ID: NCT06396897
What this study is testing
- What it's testing
- The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based care, designed to extend traditional, inpatient hospital care which may address these needs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Enrolled into IUH's H@H program
- At least 18 years of age
- Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings
- English speaking
- Able to provide consent
You likely can't join if
- Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss
- Transplant of organ other than liver
- Pregnant
- Incarcerated
- New hemodialysis
- Blood pressure \ 120, O2 \> 6L or \>2L above baseline
See the full eligibility criteria
- Enrolled into IUH's H@H program
- At least 18 years of age
- Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings
- English speaking
- Able to provide consent
- Caregiver able to be present during the acute phase of care (first 48 hours post-hospital discharge)
- Able to perform activities of daily living independently
- Lives within IU Health Home service area
- Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss
- Transplant of organ other than liver
- Pregnant
- Incarcerated
- New hemodialysis
- Blood pressure \ 120, O2 \> 6L or \>2L above baseline
- HIV+/CD4 count \< 200
- Receiving hospice services
- Concurrent enrollment in a related research study
The study team makes the final eligibility decision.
Where it's taking place
- Indianapolis, Indiana, United States
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Indianapolis, Indiana, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.